NCT02627027View on ClinicalTrials.gov

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Diabetes Mellitus, Type II
Interventions
DRUG

Duvie Tab. 0.5mg, Glucodaun OR Tab. 750mg

oral administration

DRUG

CKD-395 0.25/750mg

oral administration

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT02627027 - A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter